Literature DB >> 14760756

Expression and significance of VEGF-C and FLT-4 in gastric cancer.

Xing-E Liu1, Xiao-Dong Sun, Jin-Min Wu.   

Abstract

AIM: To investigate the expression of pathological factors of VEGF-C and its receptor FLT-4 in primary gastric cancer and adjacent normal tissues.
METHODS: The expression of VEGF-C and FLT-4 was studied in 80 primary gastric cancers and adjacent normal tissues from the same patients by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and immumohistochemistry.
RESULTS: Both primary gastric cancer and adjacent normal tissue could express VEGF-C and FLT-4, and FLT-4 expression was also detected in endothelial cells of stromal blood vessels and lymphatic vessels. There was a significant difference in expression of VEGF-C between primary tumor and adjacent normal tissue samples (P=0.01), and a statistical correlation between VEGF-C and FLT-4 expression in tumors (P=0.00886). With regard to VEGF-C expression, there was a significant difference between moderate-poor differential type and high differential type (P=0.032), and a significant difference between positive and negative lymph node metastases (P=0.024). However, there was no significant difference between positive and negative serosal invasions (P=0.219).
CONCLUSION: VEGF-C and its receptor FLT-4 play a role in the development of gastric cancer, and the tumors with expression of VEGF-C and FLT-4 are more likely to have lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14760756      PMCID: PMC4724916          DOI: 10.3748/wjg.v10.i3.352

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.

Authors:  Ruud Clarijs; Lia Schalkwijk; Uta B Hofmann; Dirk J Ruiter; Robert M W de Waal
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.

Authors:  L Jussila; R Valtola; T A Partanen; P Salven; P Heikkilä; M T Matikainen; R Renkonen; A Kaipainen; M Detmar; E Tschachler; R Alitalo; K Alitalo
Journal:  Cancer Res       Date:  1998-04-15       Impact factor: 12.701

3.  Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia.

Authors:  A Lymboussaki; B Olofsson; U Eriksson; K Alitalo
Journal:  Circ Res       Date:  1999-11-26       Impact factor: 17.367

4.  A model for gene therapy of human hereditary lymphedema.

Authors:  M J Karkkainen; A Saaristo; L Jussila; K A Karila; E C Lawrence; K Pajusola; H Bueler; A Eichmann; R Kauppinen; M I Kettunen; S Yla-Herttuala; D N Finegold; R E Ferrell; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

Review 5.  Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis.

Authors:  M J Karkkainen; T V Petrova
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

6.  VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.

Authors:  R Valtola; P Salven; P Heikkilä; J Taipale; H Joensuu; M Rehn; T Pihlajaniemi; H Weich; R deWaal; K Alitalo
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

7.  Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.

Authors:  J Lee; A Gray; J Yuan; S M Luoh; H Avraham; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

8.  Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.

Authors:  Mitsuyuki Arinaga; Tsuyoshi Noguchi; Shinsuke Takeno; Masao Chujo; Takashi Miura; Yuzo Uchida
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

9.  Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells.

Authors:  Pedram Hamrah; Lu Chen; Qiang Zhang; M Reza Dana
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

10.  VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells.

Authors:  Petri Salven; Satu Mustjoki; Riitta Alitalo; Kari Alitalo; Shahin Rafii
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

View more
  19 in total

1.  Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy.

Authors:  Zhi-Gang Sun; Zhou Wang; Xiang-Yan Liu; Fan-Ying Liu
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

2.  The effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma.

Authors:  Hongxin Zhang; Yuhui Yin; Lan Zhang; Xiangyu Zheng; Dongling Gao; Kuisheng Chen; Yunhan Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-06       Impact factor: 4.553

3.  Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer.

Authors:  Fusun Ozmen; M Mahir Ozmen; Evren Ozdemir; Munevver Moran; Selda Seçkin; Dicle Guc; Ergun Karaagaoglu; Emin Kansu
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

4.  Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats.

Authors:  Xiao-Yan Wang; Lou-Lei Wang; Xuan Zheng; Li-Na Meng; Bin Lyu; Hai-Feng Jin
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

5.  Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer.

Authors:  Yi-Tao Jia; Zhong-Xin Li; Yu-Tong He; Wei Liang; Hui-Chai Yang; Hong-Jun Ma
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

6.  Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines.

Authors:  Elizabeth A Beierle; Xiaojie Ma; Jerry E Stewart; Michael Megison; William G Cance; Elena V Kurenova
Journal:  Mol Carcinog       Date:  2012-10-12       Impact factor: 4.784

7.  Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.

Authors:  Mian He; Yang Cheng; Wen Li; Qiongshan Liu; Junxiu Liu; Jinghe Huang; Xiaodong Fu
Journal:  BMC Cancer       Date:  2010-04-29       Impact factor: 4.430

8.  K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRalpha in colorectal cancer.

Authors:  Carl C Schimanski; Tim Zimmermann; Irene Schmidtmann; Ines Gockel; Hauke Lang; Peter R Galle; Markus Moehler; Martin R Berger
Journal:  Int J Colorectal Dis       Date:  2009-11-20       Impact factor: 2.571

9.  Last line therapy with sorafenib in colorectal cancer: A retrospective analysis.

Authors:  Ksenia Martchenko; Irene Schmidtmann; Thomas Thomaidis; Verena Thole; Peter R Galle; Marc Becker; Markus Möhler; Thomas C Wehler; Carl C Schimanski
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

10.  Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma.

Authors:  Jerry E Stewart; Xiaojie Ma; Michael Megison; Hugh Nabers; William G Cance; Elena V Kurenova; Elizabeth A Beierle
Journal:  Mol Carcinog       Date:  2013-07-19       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.